Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| JPMORGAN stuft AIR FRANCE-KLM auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Air France-KLM auf "Overweight" mit einem Kursziel von 15 Euro belassen. Trotz übertroffener Erwartungen im erstenb Quartal... ► Artikel lesen |
| BARCLAYS stuft AIR FRANCE-KLM auf 'Equal Weight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Air France-KLM von 9,85 auf 9,30 Euro gesenkt und die Einstufung auf "Equal Weight" belassen. Andrew Lobbenberg... ► Artikel lesen |
| RBC stuft AIR FRANCE-KLM auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Air France-KLM von 10,50 auf 10 Euro gesenkt und die Einstufung auf "Sector Perform" belassen. Analyst Ruairi Cullinane rechnete... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group reports first quarter 2026 financial results; on track for Joenja U.S. pediatric label expansion and launches in Japan and Europe in 2026 | First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025RUCONEST revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group to report first quarter 2026 financial results and provide business update on May 7 | Leiden, the Netherlands, April 23, 2026: Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial... ► Artikel lesen |
| Pharming Group N.V.: Pharming Group announces the 2026 Annual General Meeting of Shareholders | Leiden, the Netherlands, April 16, 2026: Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM / Nasdaq: PHAR) today announced that the Company's 2026 Annual General Meeting... ► Artikel lesen |
| Galapagos NV: Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update | Galapagos' name change to Lakefront Biotherapeutics approved at the Company's EGM (Euronext & NASDAQ: LKFT)Collaboration Agreement with Gilead to advance potential First and Best-in-Class T Cell Engager... ► Artikel lesen |
| Galapagos NV: Galapagos' Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders' Meetings 2026 | Mechelen, Belgium; April 28, 2026, 22:01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the Company's Annual and Extraordinary Shareholders' Meetings (AGM... ► Artikel lesen |
| Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal | FOSTER CITY (dpa-AFX) - Galapagos (GLPG, GLPG.AS) has entered into a binding agreement with Gilead Sciences (GILD) in connection with Gilead's agreement to acquire all of the outstanding equity... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.